582 related articles for article (PubMed ID: 19372585)
41. Phenotype-rescue of cyclin-dependent kinase inhibitor p16/INK4A defects in a spontaneous canine cell model of breast cancer.
DeInnocentes P; Agarwal P; Bird RC
J Cell Biochem; 2009 Feb; 106(3):491-505. PubMed ID: 19130492
[TBL] [Abstract][Full Text] [Related]
42. Mouse p10, an alternative spliced form of p15INK4b, inhibits cell cycle progression and malignant transformation.
Pérez de Castro I; Benet M; Jiménez M; Alzabin S; Malumbres M; Pellicer A
Cancer Res; 2005 Apr; 65(8):3249-56. PubMed ID: 15833857
[TBL] [Abstract][Full Text] [Related]
43. miR-185 targets RhoA and Cdc42 expression and inhibits the proliferation potential of human colorectal cells.
Liu M; Lang N; Chen X; Tang Q; Liu S; Huang J; Zheng Y; Bi F
Cancer Lett; 2011 Feb; 301(2):151-60. PubMed ID: 21186079
[TBL] [Abstract][Full Text] [Related]
44. KIS induces proliferation and the cell cycle progression through the phosphorylation of p27Kip1 in leukemia cells.
Nakamura S; Okinaka K; Hirano I; Ono T; Sugimoto Y; Shigeno K; Fujisawa S; Shinjo K; Ohnishi K
Leuk Res; 2008 Sep; 32(9):1358-65. PubMed ID: 18384876
[TBL] [Abstract][Full Text] [Related]
45. Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells.
den Hollander P; Kumar R
Cancer Res; 2006 Jun; 66(11):5941-9. PubMed ID: 16740735
[TBL] [Abstract][Full Text] [Related]
46. Oligodendrocyte lineage transcription factor 2 inhibits the motility of a human glial tumor cell line by activating RhoA.
Tabu K; Ohba Y; Suzuki T; Makino Y; Kimura T; Ohnishi A; Sakai M; Watanabe T; Tanaka S; Sawa H
Mol Cancer Res; 2007 Oct; 5(10):1099-109. PubMed ID: 17951409
[TBL] [Abstract][Full Text] [Related]
47. Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16Ink4.
Tam SW; Shay JW; Pagano M
Cancer Res; 1994 Nov; 54(22):5816-20. PubMed ID: 7954407
[TBL] [Abstract][Full Text] [Related]
48. The COOH terminus of p18INK4C distinguishes function from p16INK4A.
Gump J; Turner S; Koh J
Cancer Res; 2001 May; 61(10):3863-8. PubMed ID: 11358797
[TBL] [Abstract][Full Text] [Related]
49. Induction of G1 cell cycle arrest and P15INK4b expression by ECRG1 through interaction with Miz-1.
Zhao N; Wang J; Cui Y; Guo L; Lu SH
J Cell Biochem; 2004 May; 92(1):65-76. PubMed ID: 15095404
[TBL] [Abstract][Full Text] [Related]
50. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
[TBL] [Abstract][Full Text] [Related]
51. Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.
Pillé JY; Denoyelle C; Varet J; Bertrand JR; Soria J; Opolon P; Lu H; Pritchard LL; Vannier JP; Malvy C; Soria C; Li H
Mol Ther; 2005 Feb; 11(2):267-74. PubMed ID: 15668138
[TBL] [Abstract][Full Text] [Related]
52. FOXO transcription factor-dependent p15(INK4b) and p19(INK4d) expression.
Katayama K; Nakamura A; Sugimoto Y; Tsuruo T; Fujita N
Oncogene; 2008 Mar; 27(12):1677-86. PubMed ID: 17873901
[TBL] [Abstract][Full Text] [Related]
53. RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells.
Laplante I; Béliveau R; Paquin J
J Neurobiol; 2004 Sep; 60(3):289-307. PubMed ID: 15281068
[TBL] [Abstract][Full Text] [Related]
54. Tumor suppressor INK4: comparisons of conformational properties between p16(INK4A) and p18(INK4C).
Yuan C; Li J; Selby TL; Byeon IJ; Tsai MD
J Mol Biol; 1999 Nov; 294(1):201-11. PubMed ID: 10556039
[TBL] [Abstract][Full Text] [Related]
55. Rho regulates p21(CIP1), cyclin D1, and checkpoint control in mammary epithelial cells.
Liberto M; Cobrinik D; Minden A
Oncogene; 2002 Feb; 21(10):1590-9. PubMed ID: 11896588
[TBL] [Abstract][Full Text] [Related]
56. Expression of the tumor suppressor ARHI inhibits the growth of pancreatic cancer cells by inducing G1 cell cycle arrest.
Lu X; Qian J; Yu Y; Yang H; Li J
Oncol Rep; 2009 Sep; 22(3):635-40. PubMed ID: 19639215
[TBL] [Abstract][Full Text] [Related]
57. Activation of protein kinase G Increases the expression of p21CIP1, p27KIP1, and histidine triad protein 1 through Sp1.
Cen B; Deguchi A; Weinstein IB
Cancer Res; 2008 Jul; 68(13):5355-62. PubMed ID: 18593937
[TBL] [Abstract][Full Text] [Related]
58. The inhibition of T-cells proliferation by mouse mesenchymal stem cells through the induction of p16INK4A-cyclin D1/cdk4 and p21waf1, p27kip1-cyclin E/cdk2 pathways.
Kim JA; Hong S; Lee B; Hong JW; Kwak JY; Cho S; Kim CC
Cell Immunol; 2007 Jan; 245(1):16-23. PubMed ID: 17470365
[TBL] [Abstract][Full Text] [Related]
59. Absence of p16 and p27 gene rearrangements and mutations in de novo myelodysplastic syndromes.
Papageorgiou SG; Pappa V; Papageorgiou E; Tsirigotis P; Kontsioti F; Panani A; Dervenoulas J; Economopoulos T
Eur J Haematol; 2005 Sep; 75(3):193-8. PubMed ID: 16104874
[TBL] [Abstract][Full Text] [Related]
60. Constitutive expression of functionally active cyclin-dependent kinases and their binding partners suggests noncanonical functions of cell cycle regulators in differentiated neurons.
Schmetsdorf S; Gärtner U; Arendt T
Cereb Cortex; 2007 Aug; 17(8):1821-9. PubMed ID: 17050646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
